MANILA, Philippines – The delivery of locally developed COVID-19 real-time reverse transcriptase polymerase chain reaction (RT-PCR) test kits is finally moving after getting the nod from the Philippines’ Food and Drug Administration (FDA). ADVERTISEMENTThe GenAmplify kits, developed by local scientists from the Philippine Genome Center (PGC) and the University of the Philippines (UP)-National Institutes of Health (NIH), would serve around 27,000 tests. “Following its FDA approval on 03 April 2020, the delivery of the locally-developed GenAmplify COVID-19 rRT-PCR for 26,000 tests is ongoing. As of now, the government said that the FDA has approved 33 COVID-19 test kits for commercial use, 23 of which are PCR test kits while 10 are rapid test kits. “Out of the 394 COVID-19 test kit application received, 99 have been approved, 226 disapproved, and 69 are pending approval due to incomplete requirements,” the government noted.

Source: Philippine Daily Inquirer April 13, 2020 20:03 UTC